Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Stability Testing of MDIs

Posted on By

SOP for Stability Testing of MDIs

MDI Stability Testing Procedures

1) Purpose

The purpose of this SOP is to outline the procedures for conducting stability testing of metered-dose inhalers (MDIs) to ensure they maintain their quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of MDIs at the manufacturing facility, including laboratory technicians and quality control staff.

3) Responsibilities

The responsibilities for this SOP include conducting stability tests according to the outlined procedures, documenting results, and ensuring compliance with regulatory standards. Specific roles include:
Laboratory Technicians: Perform stability testing as specified.
Quality Control Staff: Review and document the results of stability tests.

See also  SOP for Documentation in MDI Production

4) Procedure

4.1 Sample Preparation
4.1.1 Collect MDI samples from each batch according to the sampling plan.
4.1.2 Label and store samples under specified conditions (e.g., temperature, humidity).
4.2 Stability Testing Conditions
4.2.1 Conduct stability tests at different conditions such as long-term, accelerated, and stress conditions as per the stability protocol.
4.2.2 Record environmental conditions during testing.
4.3 Test Parameters
4.3.1 Perform physical tests (e.g., appearance, color, container integrity).
4.3.2 Conduct chemical tests (e.g., assay, impurities).
4.3.3 Perform performance tests (e.g., dose uniformity, spray pattern).
4.3.4 Conduct microbial tests if applicable.
4.4 Data Recording
4.4.1 Document all test results in the stability testing logbook.
4.4.2 Ensure data integrity and compliance with Good Laboratory Practice (GLP) guidelines.
4.5 Review and Analysis
4.5.1 Analyze the stability data to determine trends and product shelf life.
4.5.2 Review results and prepare a stability report.
4.6 Reporting
4.6.1 Submit stability reports to the quality assurance department for approval.
4.6.2 Update the stability testing schedule as required.

See also  SOP for HVAC System Maintenance in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler

6) Documents, if any

Stability testing protocols, stability reports, and environmental monitoring records should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for stability testing standards.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Application Site Testing for Transdermal Patches
Next Post: SOP for Pharmacovigilance Investigator Initiated Studies (IIS)

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version